Monitoring suPAR levels in post-kidney transplant focal segmental glomerulosclerosis treated with therapeutic plasma exchange and rituximab
Abstract Background Therapeutic plasma exchange (TPE) is an important therapy for recurrent focal segmental glomerulosclerosis (rFSGS) post kidney transplant. suPAR has been causally implicated in rFSGS, and shown to be a unique biomarker for the occurrence and progression of chronic kidney disease....
Main Authors: | Nada Alachkar, Jing Li, Dany Matar, Vikas Vujjini, Sami Alasfar, Melissa Tracy, Jochen Reiser, Changli Wei |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-12-01
|
Series: | BMC Nephrology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12882-018-1177-x |
Similar Items
-
Reassessing the Reassessment of suPAR in glomerular disease
by: Björn eMeijers, et al.
Published: (2015-01-01) -
suPAR, a Circulating Kidney Disease Factor
by: Changli Wei, et al.
Published: (2021-10-01) -
Kinetics of SuPAR hemoadsorption in critical COVID-19 patients on renal replacement therapy
by: Vaidas Vicka, et al.
Published: (2022-11-01) -
suPAR and WT1 modify the adhesion of podocytes and are related to proteinuria in class IV lupus nephritis
by: Juan-José Bollain-y-Goytia, et al.
Published: (2023-12-01) -
Concentrations of urinary neopterin, but not suPAR, positively correlate with age in rhesus macaques
by: Eve B. Cooper, et al.
Published: (2022-10-01)